Genefar B.V. is an Amsterdam based, internationally focused investment company, which has been actively investing into the healthcare space since 1993. The geographic focus is on Western-, Central and Eastern Europe. Investments made are spanning from pure generics players to biotechnology companies. One important factor is the affordability of treatments and the competitiveness of companies in each market.